<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0023">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Jin</surname>
    <given-names>Z.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Du</surname>
    <given-names>X.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xu</surname>
    <given-names>Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Deng</surname>
    <given-names>Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhao</surname>
    <given-names>Y.</given-names>
   </name>, â€¦ 
   <name name-style="western">
    <surname>Yang</surname>
    <given-names>H.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19</article-title>. 
  <source>
   <italic>BioRxiv</italic>
  </source>, 
  <volume>2020</volume>02.26.964882. 
  <pub-id pub-id-type="doi">10.1101/2020.02.26.964882</pub-id>
 </mixed-citation>
</ref>
